Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.03
Delayed Data
As of Feb 05
 +0.02 / +1.00%
Today’s Change
0.36
Today|||52-Week Range
4.37
-38.11%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close2.01
Today’s open2.02
Day’s range2.00 - 2.17
Volume120,006
Average volume (3 months)306,032
Market cap$86.5M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-12.19%
P/E ratioNM
Price/Sales4.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLCDCoLucid Pharmaceutic...+0.25+4.55%
JNPJuniper Pharmaceutic...-0.31-3.77%
ASMBAssembly Biosciences...-0.28-5.20%
CATBCatabasis Pharmaceut...-0.50-8.00%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.9M
Annual profit (last year)-$4.6M
Net profit margin-155.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts

Partner Offers